What is Colaborate?
Colaborate functions as a premier laboratory consulting firm, providing comprehensive advisory services to both independent and hospital-based laboratories. With over two decades of industry experience, the company has established itself as a critical partner for health systems navigating the complexities of modern diagnostics. Their service portfolio is extensive, covering new lab builds, test validation, and complex health system integrations. Furthermore, Colaborate distinguishes itself through specialized expertise in mergers and acquisitions, performance improvement, and regulatory compliance. By focusing on measurable cost savings and the optimization of patient care outcomes, the firm serves as a vital intermediary in the evolving landscape of medical laboratory operations.
How much funding has Colaborate raised?
Colaborate has raised a total of $25K across 1 funding round:
Debt
$25K
Debt (2021): $25K with participation from PPP
Key Investors in Colaborate
PPP
Public-Private Partnership
What's next for Colaborate?
With the infusion of this recent capital, Colaborate is poised to scale its strategic initiatives, particularly in the realms of health system integration and laboratory M&A. The firm is expected to deepen its footprint in the U.S. market by enhancing its proprietary consulting frameworks and expanding its team of subject matter experts. As the healthcare industry continues to prioritize operational efficiency and diagnostic accuracy, Colaborate's focus on performance improvement will likely serve as a primary growth driver. Future efforts will likely center on digitizing laboratory workflows and expanding their compliance advisory services to meet the increasing regulatory demands placed on hospital-based diagnostic facilities.
See full Colaborate company page
